Literature DB >> 8413031

A mathematical basis for selection of wedge angle and orientation.

G W Sherouse1.   

Abstract

The treatment plan optimization criterion that dose be homogeneous over an irradiated volume is equivalent to the criterion that the magnitude of the dose gradient be zero throughout that volume. If the dose gradient due to an individual beam is represented by a vector, the dose gradient due to an ensemble of beams is given by the weighted vector sum of the constituent beams' individual gradients. Given a fixed ensemble of beams, the two ways in which the total dose gradient can be modified are (1) by changes in relative beam weights and/or (2) by changes in the direction and/or magnitude of the dose gradient of one or more of the individual beams. Conventional wedges provide a simple mechanism for altering the dose gradient of a single beam. This paper describes a mathematical basis for the selection of wedge angles, wedge orientations, and relative beam weights, with the goal of producing a field of zero gradient over the volume of beam intersection. The approach is based on 3-dimensional vector analysis of dose gradients, and is valuable not only for its formalism, but also for the conceptual basis it provides for discussing and solving general wedge selection problems.

Mesh:

Year:  1993        PMID: 8413031     DOI: 10.1118/1.596972

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  3 in total

1.  Dose gradient based algorithm for beam weights selection in 3D-CRT plans.

Authors:  Marta Krystyna Giżyńska; Paweł F Kukołowicz
Journal:  Rep Pract Oncol Radiother       Date:  2014-05-13

2.  Implementation of a dose gradient method into optimization of dose distribution in prostate cancer 3D-CRT plans.

Authors:  Marta K Giżyńska; Paweł F Kukołowicz; Paweł Kordowski
Journal:  Rep Pract Oncol Radiother       Date:  2014-05-03

3.  Comparison of two algorithms for determining beam weights and wedge filters.

Authors:  Jianrong Dai; Yunping Zhu
Journal:  J Appl Clin Med Phys       Date:  2002       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.